Green Cross LabCell, 11.46% Rise Amid Cord Blood Theme Uptrend

On the 11th, the umbilical cord blood theme rose by 3.56% compared to the previous day, showing strength, while Green Cross Labcell, a related stock drawing attention, surged by 11.46% compared to the previous day. Green Cross Labcell is known as a cell therapy research and development company.

[Graph] Major Stocks' Price Changes in the Umbilical Cord Blood Theme



According to the analysis by Thinkpool Robo Algorithm RASSI, Green Cross Labcell's quant financial score is 19.02 points, ranking 3rd within the umbilical cord blood theme due to higher growth and stability scores compared to the average of other related stocks. This indicates that, compared to other stocks in the theme, Green Cross Labcell has a relatively fast growth rate in sales and net profit, and also demonstrates good responsiveness to changes in domestic and international economic environments.

[Table] Top Financial Scores within the Theme


※ The quant financial score is the result of the robo algorithm analyzing each company's sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, and other factors.

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.